These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25349150)

  • 1. Plasma leptin levels are not predictive of dementia in patients with mild cognitive impairment.
    Oania R; McEvoy LK
    Age Ageing; 2015 Jan; 44(1):53-8. PubMed ID: 25349150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbid Mild Cognitive Impairment and Depressive Symptoms Predict Future Dementia in Community Older Adults: A 24-Month Follow-Up Longitudinal Study.
    Makizako H; Shimada H; Doi T; Tsutsumimoto K; Hotta R; Nakakubo S; Makino K; Suzuki T
    J Alzheimers Dis; 2016 Oct; 54(4):1473-1482. PubMed ID: 27589518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of Dementia and Mild Cognitive Impairment in Patients With Atrial Fibrillation: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).
    Alonso A; Knopman DS; Gottesman RF; Soliman EZ; Shah AJ; O'Neal WT; Norby FL; Mosley TH; Chen LY
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28739861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin, mild cognitive impairment, and dementia among elderly women.
    Zeki Al Hazzouri A; Stone KL; Haan MN; Yaffe K
    J Gerontol A Biol Sci Med Sci; 2013 Feb; 68(2):175-80. PubMed ID: 22859388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.
    Di Carlo A; Baldereschi M; Lamassa M; Bovis F; Inzitari M; Solfrizzi V; Panza F; Galluzzo L; Scafato E; Inzitari D;
    J Alzheimers Dis; 2016 May; 53(2):505-15. PubMed ID: 27163817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Blood caffeine levels in MCI linked to lack of progression to dementia.
    Cao C; Loewenstein DA; Lin X; Zhang C; Wang L; Duara R; Wu Y; Giannini A; Bai G; Cai J; Greig M; Schofield E; Ashok R; Small B; Potter H; Arendash GW
    J Alzheimers Dis; 2012; 30(3):559-72. PubMed ID: 22430531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.
    Mielke MM; Hagen CE; Wennberg AMV; Airey DC; Savica R; Knopman DS; Machulda MM; Roberts RO; Jack CR; Petersen RC; Dage JL
    JAMA Neurol; 2017 Sep; 74(9):1073-1080. PubMed ID: 28692710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis.
    Iulita MF; Ganesh A; Pentz R; Flores Aguilar L; Gubert P; Ducatenzeiler A; Christie S; Wilcock GK; Cuello AC
    J Alzheimers Dis; 2019; 67(1):327-341. PubMed ID: 30636741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dementia prediction for people with stroke in populations: is mild cognitive impairment a useful concept?
    Stephan BC; Minett T; Terrera GM; Matthews FE; Brayne C
    Age Ageing; 2015 Jan; 44(1):78-83. PubMed ID: 25002454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
    J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affective Neuropsychiatric Symptoms as Early Signs of Dementia Risk in Older Adults.
    Jang JY; Ho JK; Blanken AE; Dutt S; Nation DA;
    J Alzheimers Dis; 2020; 77(3):1195-1207. PubMed ID: 32925031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of leptin on memory function and hippocampal structure in mild cognitive impairment.
    Witte AV; Köbe T; Graunke A; Schuchardt JP; Hahn A; Tesky VA; Pantel J; Flöel A
    Hum Brain Mapp; 2016 Dec; 37(12):4539-4549. PubMed ID: 27511061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of Functional Cognition and Complex Everyday Activities in Older Adults with Mild Cognitive Impairment and Mild Dementia: Validity of the Large Allen's Cognitive Level Screen.
    Wesson J; Clemson L; Crawford JD; Kochan NA; Brodaty H; Reppermund S
    Am J Geriatr Psychiatry; 2017 May; 25(5):471-482. PubMed ID: 28238815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification.
    Korolev IO; Symonds LL; Bozoki AC;
    PLoS One; 2016; 11(2):e0138866. PubMed ID: 26901338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study.
    Tondelli M; Bedin R; Chiari A; Molinari MA; Bonifacio G; Lelli N; Trenti T; Nichelli P
    Clin Chem Lab Med; 2015 Feb; 53(3):453-60. PubMed ID: 25274948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.